These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 9139676)

  • 41. Analysis of the Inhibitory Elements in the p5 Peptide Fragment of the CDK5 Activator, p35, CDKR1 Protein.
    Binukumar BK; Shukla V; Amin ND; Bhaskar M; Skuntz S; Steiner J; Winkler D; Pelech SL; Pant HC
    J Alzheimers Dis; 2015; 48(4):1009-17. PubMed ID: 26444778
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The regulation of cyclin-dependent kinase 5 activity through the metabolism of p35 or p39 Cdk5 activator.
    Hisanaga S; Saito T
    Neurosignals; 2003; 12(4-5):221-9. PubMed ID: 14673209
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The cyclin-dependent kinases cdk2 and cdk5 act by a random, anticooperative kinetic mechanism.
    Clare PM; Poorman RA; Kelley LC; Watenpaugh KD; Bannow CA; Leach KL
    J Biol Chem; 2001 Dec; 276(51):48292-9. PubMed ID: 11604388
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The protein kinase Cdk5. Structural aspects, roles in neurogenesis and involvement in Alzheimer's pathology.
    Maccioni RB; Otth C; Concha II; Muñoz JP
    Eur J Biochem; 2001 Mar; 268(6):1518-27. PubMed ID: 11248668
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Different mechanisms of CDK5 and CDK2 activation as revealed by CDK5/p25 and CDK2/cyclin A dynamics.
    Otyepka M; Bártová I; Kríz Z; Koca J
    J Biol Chem; 2006 Mar; 281(11):7271-81. PubMed ID: 16407256
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Crystal structure of a viral cyclin, a positive regulator of cyclin-dependent kinase 6.
    Schulze-Gahmen U; Jung JU; Kim SH
    Structure; 1999 Mar; 7(3):245-54. PubMed ID: 10368294
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Molecular cloning and characterisation of a mouse gene encoding an isoform of the neuronal cyclin-dependent kinase 5 (CDK5) activator.
    Nildén F; Bäckström A; Bark C
    Biochim Biophys Acta; 1998 Jul; 1398(3):371-6. PubMed ID: 9655938
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The role of cyclin-dependent kinase 5 and a novel regulatory subunit in regulating muscle differentiation and patterning.
    Philpott A; Porro EB; Kirschner MW; Tsai LH
    Genes Dev; 1997 Jun; 11(11):1409-21. PubMed ID: 9192869
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Identification of the N-terminal functional domains of Cdk5 by molecular truncation and computer modeling.
    Zhang J; Luan CH; Chou KC; Johnson GV
    Proteins; 2002 Aug; 48(3):447-53. PubMed ID: 12112670
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The brain-specific activator p35 allows Cdk5 to escape inhibition by p27Kip1 in neurons.
    Lee MH; Nikolic M; Baptista CA; Lai E; Tsai LH; Massagué J
    Proc Natl Acad Sci U S A; 1996 Apr; 93(8):3259-63. PubMed ID: 8622924
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The p35/Cdk5 kinase is a neuron-specific Rac effector that inhibits Pak1 activity.
    Nikolic M; Chou MM; Lu W; Mayer BJ; Tsai LH
    Nature; 1998 Sep; 395(6698):194-8. PubMed ID: 9744280
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Molecular characterization of a neuronal-specific protein that stimulates the activity of Cdk5.
    Shetty KT; Kaech S; Link WT; Jaffe H; Flores CM; Wray S; Pant HC; Beushausen S
    J Neurochem; 1995 May; 64(5):1988-95. PubMed ID: 7536802
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The structure of cyclin H: common mode of kinase activation and specific features.
    Andersen G; Busso D; Poterszman A; Hwang JR; Wurtz JM; Ripp R; Thierry JC; Egly JM; Moras D
    EMBO J; 1997 Mar; 16(5):958-67. PubMed ID: 9118957
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A brain-specific activator of cyclin-dependent kinase 5.
    Lew J; Huang QQ; Qi Z; Winkfein RJ; Aebersold R; Hunt T; Wang JH
    Nature; 1994 Sep; 371(6496):423-6. PubMed ID: 8090222
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The role of the Cdk5--p35 kinase in neuronal development.
    Paglini G; Cáceres A
    Eur J Biochem; 2001 Mar; 268(6):1528-33. PubMed ID: 11248669
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Crystal structure of the p27Kip1 cyclin-dependent-kinase inhibitor bound to the cyclin A-Cdk2 complex.
    Russo AA; Jeffrey PD; Patten AK; Massagué J; Pavletich NP
    Nature; 1996 Jul; 382(6589):325-31. PubMed ID: 8684460
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Critical role for the 310 helix region of p57(Kip2) in cyclin-dependent kinase 2 inhibition and growth suppression.
    Hashimoto Y; Kohri K; Kaneko Y; Morisaki H; Kato T; Ikeda K; Nakanishi M
    J Biol Chem; 1998 Jun; 273(26):16544-50. PubMed ID: 9632724
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Targeted disruption of the cyclin-dependent kinase 5 gene results in abnormal corticogenesis, neuronal pathology and perinatal death.
    Ohshima T; Ward JM; Huh CG; Longenecker G; Veeranna ; Pant HC; Brady RO; Martin LJ; Kulkarni AB
    Proc Natl Acad Sci U S A; 1996 Oct; 93(20):11173-8. PubMed ID: 8855328
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Identification of a p130 domain mediating interactions with cyclin A/cdk 2 and cyclin E/cdk 2 complexes.
    Lacy S; Whyte P
    Oncogene; 1997 May; 14(20):2395-406. PubMed ID: 9188854
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Region-specific expression of cyclin-dependent kinase 5 (cdk5) and its activators, p35 and p39, in the developing and adult rat central nervous system.
    Zheng M; Leung CL; Liem RK
    J Neurobiol; 1998 May; 35(2):141-59. PubMed ID: 9581970
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.